Welcome to our dedicated page for European Wax Center news (Ticker: EWCZ), a resource for investors and traders seeking the latest updates and insights on European Wax Center stock.
European Wax Center, Inc. (NASDAQ: EWCZ) is described as the leading franchisor and operator of out-of-home waxing services in the United States, and its news flow reflects both its consumer brand and its franchise-based growth model. Company announcements frequently highlight system-wide sales performance, total revenue, same-store sales trends, and center openings and closures across its network of more than 1,000 locations.
Investors and observers following EWCZ news can expect regular quarterly earnings releases that discuss financial results, non-GAAP measures such as Adjusted EBITDA and Adjusted Net Income, and updates to the company’s fiscal outlook. These releases often include commentary from leadership on strategic priorities, including driving traffic and sales growth, improving four-wall profitability for franchisees, and pursuing disciplined or thoughtful, profitable expansion of the center network.
European Wax Center’s news also covers executive leadership developments and governance updates, such as appointments of key executives and changes in board composition, which are sometimes accompanied by Form 8-K filings. In addition, the company issues product-related announcements, including launches within its proprietary EWC TREAT® line, such as the EWC TREAT® All Over Deodorant, which is positioned to complement its waxing services and extend results between visits.
Conference call and webcast notices appear regularly in the news stream, providing details on upcoming earnings calls and investor presentations. For anyone tracking EWCZ stock, this news page offers a centralized view of operational updates, financial guidance changes, leadership announcements, and product introductions that the company has chosen to disclose publicly.
European Wax Center (NASDAQ: EWCZ), the leading U.S. out-of-home waxing services franchisor, reported Q2 2025 results with mixed performance. System-wide sales decreased 1.0% to $257.6 million, while total revenue declined 6.6% to $55.9 million. Same-store sales showed a modest increase of 0.3%.
The company's net income decreased 9.0% to $5.4 million, while Adjusted EBITDA improved 4.7% to $21.6 million. The company maintained its network of 1,059 centers across 44 states, with 2 openings and 5 closures during the quarter.
European Wax Center revised its fiscal 2025 outlook, lowering system-wide sales expectations to $940-950 million (from $940-960 million) and total revenue to $205-209 million (from $210-214 million). The company expects 28 to 50 net center closings in fiscal 2025.
European Wax Center (NASDAQ: EWCZ), the leading franchisor of waxing services, has launched its first-ever EWC TREAT® All Over Deodorant, expanding its product portfolio. The $18 aluminum-free cream deodorant is designed for full-body use, featuring a unique formula that combines odor protection with hair thickness reduction properties.
The product contains key ingredients including Glycolic Acid for odor neutralization, Prebiotics for skin balance, and Narcissus Bulb Extract for hair thickness reduction. The dermatologist and gynecologist-tested formula is available through waxcenter.com and European Wax Center locations nationwide.
European Wax Center (NASDAQ: EWCZ), the leading U.S. franchisor of out-of-home waxing services, will release its Q2 2025 financial results on August 13, 2025, before market open. Management will host a conference call at 8:00 a.m. ET to discuss the results.
The company operates over 1,000 centers across 44 states and performed more than 23 million services annually. In fiscal 2024, the network generated sales of $951 million. European Wax Center is known for its innovative Comfort Wax® formulation and is Certified™ by Great Place to Work®.
European Wax Center (NASDAQ: EWCZ), the leading out-of-home waxing services franchisor, has achieved significant recognition in Entrepreneur Magazine's 2025 franchise rankings. The company secured a top 20 position in the Top Franchises for Multi-Unit Owners list, improving from its 2024 ranking, and maintained its position as the top waxing franchise in the Best of the Best Franchises list.
CEO Chris Morris highlighted that the majority of their franchisees are multi-unit owners, with 20% operating five or more centers. The company, which has over 1,000 locations nationwide, provides comprehensive support to franchisees, including training, marketing, real estate guidance, and guest retention tools.
European Wax Center (NASDAQ: EWCZ), the leading U.S. out-of-home waxing services franchisor, has announced two key executive appointments. Angela Jaskolski will join as Chief Operating Officer effective August 18, 2025, bringing over 20 years of executive experience from companies including Madison Reed. Kurt Smith will assume the role of Chief Development Officer effective July 22, 2025, with nearly 20 years of global leadership experience, most recently at Pizza Hut.
Jaskolski will oversee Franchise Operations, Field Training, Learning and Development, and Industry Engagement, while Smith will lead Business Development, Real Estate, Market Planning, and Franchise Recruitment. Both executives will report to CEO Chris Morris as part of the company's strategy to strengthen operations and drive growth.
European Wax Center (NASDAQ: EWCZ), America's leading franchisor of out-of-home waxing services, will release its Q1 fiscal 2025 financial results on May 14, 2025, before market opening. Management will host a conference call at 8:00 a.m. ET to discuss the results.
The company stands as a dominant force in the waxing industry with:
- Over 1,000 centers across 45 states
- 23 million+ services performed annually
- $951 million in sales for fiscal 2024
- Proprietary Comfort Wax® formula
The company's success is built on core values including guest delight, team care, and ethical practices, earning them Great Place to Work® certification. Founded in 2004 and headquartered in Plano, Texas, European Wax Center provides professional waxing services in private, clean suites by trained specialists.
European Wax Center (NASDAQ: EWCZ), the leading U.S. franchisor of out-of-home waxing services, has announced equity grants for its new Chief Financial Officer Thomas Kim. The grants, effective April 7, 2025, include:
- 200,000 restricted stock units (RSUs) of Class A common stock
- 310,000 stock options at $3.51 exercise price
- 212,500 stock options at $9.00 exercise price
- 212,500 stock options at $12.00 exercise price
The RSUs will vest in equal installments over four years, while all stock options will fully vest on April 7, 2029. These grants were made under the company's 2025 Inducement Plan, specifically designed for new employees as per Nasdaq Rule 5635(c)(4).
European Wax Center (NASDAQ: EWCZ) has announced the launch of its new EWC SLOW® Face & Body Bi-Phase Moisturizer, expanding its SLOW product line. The dual-phase moisturizer, priced at $20, will be available through waxcenter.com and at European Wax Center locations from April 1, 2025.
The product features key ingredients including:
- Narcissus Bulb Extract to reduce hair thickness between waxes
- Aloe for skin soothing
- Hyaluronic Acid for multi-layer hydration
- Moringa Oil to restore skin's moisture barrier
The clinically tested formula provides 24-hour moisturization and aims to enhance the waxing experience by maintaining smoother-looking skin between treatments.
European Wax Center (NASDAQ: EWCZ) announced Board approval for equity grants to one new employee effective March 31, 2025. The grants include:
- 84,000 restricted stock units (RSUs) of Class A common stock
- 130,000 stock options at $3.95 exercise price
- 95,000 stock options at $9.00 exercise price
- 95,000 stock options at $12.00 exercise price
The RSUs will vest in equal installments over four years, while all stock options will fully vest on March 31, 2029. These grants were made under the company's 2025 Inducement Plan, specifically designed for new hires as per Nasdaq Rule 5635(c)(4).